Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash-to-Debt 0.62
CASM's Cash-to-Debt is ranked lower than
61% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.62 vs. CASM: 0.62 )
Ranked among companies with meaningful Cash-to-Debt only.
CASM' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.07  Med: 0.72 Max: No Debt
Current: 0.62
Equity-to-Asset 0.18
CASM's Equity-to-Asset is ranked lower than
91% of the 184 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.58 vs. CASM: 0.18 )
Ranked among companies with meaningful Equity-to-Asset only.
CASM' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.18  Med: 0.58 Max: 0.86
Current: 0.18
0.18
0.86
Piotroski F-Score: 3
Altman Z-Score: -2.11
Beneish M-Score: -3.58
WACC vs ROIC
-1.90%
-94.06%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating Margin % -22.62
CASM's Operating Margin % is ranked lower than
76% of the 187 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.86 vs. CASM: -22.62 )
Ranked among companies with meaningful Operating Margin % only.
CASM' s Operating Margin % Range Over the Past 10 Years
Min: -47.7  Med: -25.37 Max: 1.51
Current: -22.62
-47.7
1.51
Net Margin % -29.47
CASM's Net Margin % is ranked lower than
71% of the 187 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.79 vs. CASM: -29.47 )
Ranked among companies with meaningful Net Margin % only.
CASM' s Net Margin % Range Over the Past 10 Years
Min: -47.28  Med: -25.11 Max: 0.8
Current: -29.47
-47.28
0.8
ROE % -167.91
CASM's ROE % is ranked lower than
89% of the 182 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.30 vs. CASM: -167.91 )
Ranked among companies with meaningful ROE % only.
CASM' s ROE % Range Over the Past 10 Years
Min: -187.76  Med: -50.3 Max: 2.32
Current: -167.91
-187.76
2.32
ROA % -40.92
CASM's ROA % is ranked lower than
75% of the 191 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.23 vs. CASM: -40.92 )
Ranked among companies with meaningful ROA % only.
CASM' s ROA % Range Over the Past 10 Years
Min: -53.75  Med: -30.02 Max: 1.35
Current: -40.92
-53.75
1.35
ROC (Joel Greenblatt) % -97.27
CASM's ROC (Joel Greenblatt) % is ranked lower than
76% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.88 vs. CASM: -97.27 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
CASM' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -177.41  Med: -103.9 Max: 4.33
Current: -97.27
-177.41
4.33
3-Year Revenue Growth Rate -15.80
CASM's 3-Year Revenue Growth Rate is ranked lower than
83% of the 148 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.10 vs. CASM: -15.80 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
CASM' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -23.7  Med: 7.8 Max: 25.3
Current: -15.8
-23.7
25.3
3-Year EBITDA Growth Rate -36.30
CASM's 3-Year EBITDA Growth Rate is ranked lower than
94% of the 126 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.80 vs. CASM: -36.30 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
CASM' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -36.3  Med: -12.45 Max: 109.2
Current: -36.3
-36.3
109.2
3-Year EPS without NRI Growth Rate -31.00
CASM's 3-Year EPS without NRI Growth Rate is ranked lower than
85% of the 122 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.10 vs. CASM: -31.00 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
CASM' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -37  Med: -4.85 Max: 136.8
Current: -31
-37
136.8
GuruFocus has detected 3 Warning Signs with CAS Medical Systems Inc $CASM.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» CASM's 30-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q2 2016

CASM Guru Trades in Q2 2016

Jim Simons 242,700 sh (+58.01%)
» More
Q3 2016

CASM Guru Trades in Q3 2016

Jim Simons 250,399 sh (+3.17%)
» More
Q4 2016

CASM Guru Trades in Q4 2016

Jim Simons 255,000 sh (+1.84%)
» More
Q1 2017

CASM Guru Trades in Q1 2017

Jim Simons 257,000 sh (+0.78%)
» More
» Details

Insider Trades

Latest Guru Trades with CASM

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies    NAICS: 339112    SIC: 3841
Compare:NAS:BLFS, AMEX:DXR, AMEX:INFU, OTCPK:LDSYF, NAS:PDEX, NAS:ATEC, NAS:BMRA, AMEX:ISR, NAS:VLRX, AMEX:RVP, OTCPK:REPR, AMEX:MLSS, OTCBB:NEPH, NAS:EKSO, OTCPK:STXS, NAS:AKER, OTCPK:IGAP, NAS:SKLN, OTCPK:UEEC, OTCPK:VPTDF » details
Traded in other countries:UM1.Germany,
Headquarter Location:USA
CAS Medical Systems Inc is a medical technology company. The Company develops, manufactures and markets non-invasive patient monitoring products that are vital to patient care. Its products include FORE-SIGHT and FORE-SIGHT ELITE brand.

CAS Medical Systems Inc is a medical technology company that develops, manufactures, and markets non-invasive patient monitoring products. The company's products are the FORE-SIGHT and FORE-SIGHT ELITE brand tissue oximeters and sensors. .

Top Ranked Articles about CAS Medical Systems Inc

CASMED to Report First-Quarter 2017 Financial Results and Hold Conference Call on May 3
CASMED to Present at the ROTH Conference

BRANFORD, Conn., March 10, 2017 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (NASDAQ:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, announces that Thomas M. Patton, President and Chief Executive Officer, will present at the 29th Annual ROTH Conference on Tuesday, March 14, 2017, at 2:30 p.m. Pacific time (5:30 p.m. Eastern time).  The conference is being held at The Ritz Carlton Laguna Niguel hotel in Dana Point, California.
Mr. Patton will be available for one-on-one meetings with the investment community on Tuesday, March 14. Please contact ROTH Capital Partners via the conference website if you would like to arrange a meeting. Interested parties can access the audio webcast with slide presentation at www.casmed.com or directly at http://wsw.com/webcast/roth31/casm. An archived presentation will be available for 90 days. About CASMED® – Monitoring What's Vital CASMED products are designed to provide unique non-invasive monitoring solutions that are vital to patient care. The Company's FORE-SIGHT® Cerebral Oximeters provide a highly accurate, non-invasive measurement of tissue oxygenation in the brain.  Direct monitoring of tissue oxygenation can provide a superior and powerful tool to alert clinicians to otherwise unrecognized and dangerously low levels of oxygen in the brain and empower them to improve patient care.  In addition to FORE-SIGHT oximeters and accessories, the Company also provides proprietary non-invasive blood pressure monitoring solutions for OEM use. For further information regarding CASMED, visit the Company's website at www.casmed.com. Company Contact
CAS Medical Systems, Inc.
Jeffery A. Baird
Chief Financial Officer
(203) 315-6303
[email protected]

 

Investors
LHA
Bruce Voss / Jody Cain
(310) 691-7100
[email protected] / [email protected]
@LHA_IR_PR 


Read more...
CASMED to Report Fourth-Quarter and 2016 Full-Year Financial Results and Hold Conference Call on March 9

BRANFORD, Conn., March 02, 2017 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (NASDAQ:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, announces that it will report financial results for the fourth quarter and full-year 2016 on Thursday, March 9, 2017, prior to the market’s opening.  Management will host a conference call to discuss these results and answer questions at 10:00 a.m. Eastern time that day.
Conference call dial-in information is as follows: U.S. callers:  (866) 239-5859 
International callers: (702) 495-1913
Individuals interested in listening to the live conference call via the Internet may do so by logging on to the Company's website: www.casmed.com. A telephone replay will be available from 1:00 p.m. Eastern time on March 9, 2017, through 11:59 p.m. Eastern time on March 23, 2017.  Replay dial-in information is as follows: U.S. callers: (855) 859-2056  
International callers: (404) 537-3406  
Conference ID number (U.S. and international): 68572530
The replay will also be available at www.casmed.com.
About CASMED® - Monitoring What's Vital CASMED products are designed to provide unique non-invasive monitoring solutions that are vital to patient care. The Company's FORE-SIGHT® Cerebral Oximeters provide a highly accurate, non-invasive measurement of tissue oxygenation in the brain.  Direct monitoring of tissue oxygenation can provide a superior and powerful tool to alert clinicians to otherwise unrecognized and dangerously low levels of oxygen in the brain and empower them to improve patient care.  In addition to FORE-SIGHT oximeters and accessories, the Company also provides proprietary non-invasive blood pressure monitoring solutions for OEM use. For further information regarding CASMED, visit the Company's website at www.casmed.com. Company Contacts
CAS Medical Systems, Inc.
Jeffery A. Baird
Chief Financial Officer
(203) 315-6303
[email protected] Investors
LHA
Bruce Voss / Jody Cain
(310) 691-7100
[email protected]
[email protected]
@LHA_IR_PR


Read more...

Ratios

vs
industry
vs
history
PS Ratio 1.17
CASM's PS Ratio is ranked higher than
70% of the 180 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.01 vs. CASM: 1.17 )
Ranked among companies with meaningful PS Ratio only.
CASM' s PS Ratio Range Over the Past 10 Years
Min: 0.38  Med: 1.39 Max: 3.13
Current: 1.17
0.38
3.13
EV-to-EBIT -8.84
CASM's EV-to-EBIT is ranked lower than
99.99% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 24.30 vs. CASM: -8.84 )
Ranked among companies with meaningful EV-to-EBIT only.
CASM' s EV-to-EBIT Range Over the Past 10 Years
Min: -804.2  Med: -6.7 Max: 133.9
Current: -8.84
-804.2
133.9
EV-to-EBITDA -11.05
CASM's EV-to-EBITDA is ranked lower than
99.99% of the 203 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 17.15 vs. CASM: -11.05 )
Ranked among companies with meaningful EV-to-EBITDA only.
CASM' s EV-to-EBITDA Range Over the Past 10 Years
Min: -147.8  Med: -6.1 Max: 135
Current: -11.05
-147.8
135
Current Ratio 2.20
CASM's Current Ratio is ranked higher than
51% of the 187 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.54 vs. CASM: 2.20 )
Ranked among companies with meaningful Current Ratio only.
CASM' s Current Ratio Range Over the Past 10 Years
Min: 2.12  Med: 3.46 Max: 9.01
Current: 2.2
2.12
9.01
Quick Ratio 1.81
CASM's Quick Ratio is ranked higher than
66% of the 187 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.67 vs. CASM: 1.81 )
Ranked among companies with meaningful Quick Ratio only.
CASM' s Quick Ratio Range Over the Past 10 Years
Min: 0.87  Med: 2.1 Max: 7.36
Current: 1.81
0.87
7.36
Days Inventory 59.56
CASM's Days Inventory is ranked higher than
89% of the 175 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 124.79 vs. CASM: 59.56 )
Ranked among companies with meaningful Days Inventory only.
CASM' s Days Inventory Range Over the Past 10 Years
Min: 54.69  Med: 105.87 Max: 192.61
Current: 59.56
54.69
192.61
Days Sales Outstanding 51.33
CASM's Days Sales Outstanding is ranked higher than
62% of the 153 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 61.76 vs. CASM: 51.33 )
Ranked among companies with meaningful Days Sales Outstanding only.
CASM' s Days Sales Outstanding Range Over the Past 10 Years
Min: 33.05  Med: 44.22 Max: 54.73
Current: 51.33
33.05
54.73
Days Payable 41.97
CASM's Days Payable is ranked lower than
67% of the 145 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 53.53 vs. CASM: 41.97 )
Ranked among companies with meaningful Days Payable only.
CASM' s Days Payable Range Over the Past 10 Years
Min: 31.49  Med: 39.65 Max: 59.01
Current: 41.97
31.49
59.01

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -12.40
CASM's 3-Year Average Share Buyback Ratio is ranked lower than
74% of the 120 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -3.20 vs. CASM: -12.40 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
CASM' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -25.9  Med: -3.1 Max: 0.6
Current: -12.4
-25.9
0.6

Valuation & Return

vs
industry
vs
history
Price-to-Median-PS-Value 0.83
CASM's Price-to-Median-PS-Value is ranked lower than
58% of the 148 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.14 vs. CASM: 0.83 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
CASM' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0  Med: 0.93 Max: 2.74
Current: 0.83
0
2.74
Earnings Yield (Greenblatt) % -11.31
CASM's Earnings Yield (Greenblatt) % is ranked lower than
85% of the 267 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.18 vs. CASM: -11.31 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
CASM' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -11.31  Med: 2.9 Max: 3.7
Current: -11.31
-11.31
3.7
Forward Rate of Return (Yacktman) % -29.22
CASM's Forward Rate of Return (Yacktman) % is ranked lower than
96% of the 90 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.64 vs. CASM: -29.22 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
CASM' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -29.22  Med: -3.6 Max: 41.5
Current: -29.22
-29.22
41.5

More Statistics

Revenue (TTM) (Mil) $22.01
EPS (TTM) $ -0.29
Beta-1.35
Short Percentage of Float0.27%
52-Week Range $0.80 - 2.15
Shares Outstanding (Mil)28.23
» More Articles for CASM

Headlines

Articles On GuruFocus.com
CASMED to Report First-Quarter 2017 Financial Results and Hold Conference Call on May 3 Apr 26 2017 
CASMED to Present at the ROTH Conference Mar 10 2017 
CASMED to Report Fourth-Quarter and 2016 Full-Year Financial Results and Hold Conference Call on Mar Mar 02 2017 
CAS Medical Systems Inc. (CASM) CEO Thomas M Patton buys 20,000 Shares Dec 08 2010 
CAS Medical Systems Inc. Reports Operating Results (10-Q) Nov 10 2010 
CAS Medical Systems Inc. Reports Operating Results (10-Q) Aug 04 2010 
CAS Medical Systems Inc. Reports Operating Results (10-Q) May 05 2010 
CAS Medical Systems Inc. Reports Operating Results (10-Q) Nov 05 2009 
CAS Medical Systems Inc. Reports Operating Results (10-Q) Aug 12 2009 
CAS Medical Systems Inc. Reports Operating Results (10-Q) May 06 2009 

More From Other Websites
CASM: Expect Salesforce Productivity, Revenue Acceleration in 2H May 08 2017
CASMED Reports First-Quarter 2017 Financial Results May 03 2017
Investor Network: CAS Medical Systems, Inc. to Host Earnings Call May 03 2017
CASMED to Report First-Quarter 2017 Financial Results and Hold Conference Call on May 3 Apr 26 2017
ETFs with exposure to CAS Medical Systems, Inc. : April 20, 2017 Apr 20 2017
CAS Medical Systems, Inc. :CASM-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017 Mar 20 2017
CASM: 2017 Shaping Up To Be Another Record Year Mar 15 2017
CASMED to Present at the ROTH Conference Mar 10 2017
Edited Transcript of CASM earnings conference call or presentation 9-Mar-17 3:00pm GMT Mar 09 2017
CASMED Reports 2016 Fourth-Quarter and Full-Year Financial Results Mar 09 2017
CASMED to Report Fourth-Quarter and 2016 Full-Year Financial Results and Hold Conference Call on... Mar 02 2017
CASM: Q4 Revenue Growth of 14%, Further Acceleration in 2H 2017 Jan 13 2017
How Cogentix Medical Inc (CGNT) Ranks Amongst Its Peers Dec 19 2016
ETFs with exposure to CAS Medical Systems, Inc. : December 16, 2016 Dec 16 2016
ETFs with exposure to CAS Medical Systems, Inc. : November 16, 2016 Nov 16 2016
CAS Medical Systems, Inc. :CASM-US: Earnings Analysis: Q3, 2016 By the Numbers : November 9, 2016 Nov 09 2016
Edited Transcript of CASM earnings conference call or presentation 8-Nov-16 3:00pm GMT Nov 08 2016
ETF’s with exposure to CAS Medical Systems, Inc. : October 20, 2016 Oct 20 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}